Aim: To evaluate the impact of dexamethasone (DEX) as a cost-effective drug to prevent Postoperative nausea and vomiting (PONV) in comparison to ondansetron in laparoscopic surgery. Methods: In this randomized control study, we included 100 patients, who underwent llaparoscopic surgery under general anesthesia at Nishtar Hospital Multan. Within 6 months from 21 Jan 2018 to 20 June 2019. Patients were divided into Group I, and Group II. Group I; in these patients intravenous (IV) DEX 8 mg was given at the time of inductionjof anesthesia. Group II; in these patients, Ondansetron (4 mg) IV was given at the time of iinduction of anesthesia. After completing the surgery and shifted the patient to the recovery room, the observation was done for early 6 hours of post-operative and noted down with the occurrence of PONV. Results: The demographic profile which includes age, weight, sex, BMI, ASA I and ASA II were comparable and there were no significantddifferences [p>0.05] wereoobserved between the two groups. PONV occurred in 11 (22%) patients in the DEX group and 21(42%) patients in the ondansetronngroup (p-value 0.03). Conclusion: DEX reduced the incidence of PONV after laparoscopiccsurgery. A single dose of DEX was found to b a safe and cost-effective alternative to single-dose ondansetron for the prevention of PONV.